DexCom (DXCM) has opened its manufacturing facility in Athenry, Ireland, as part of its efforts to expand its manufacturing presence in Europe, the Middle East and Africa, the company said Thursday.
The California-based company, which makes continuous glucose monitoring systems, broke ground on the facility in 2024, with plans to invest roughly 300 million euros ($329.8 million) over five years and create more than 1,000 jobs.
The site currently employs about 500 members, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments